Fund moves
7 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
AXTA · NYSE · Specialty Chemicals
Axalta (AXTA) · oqro.io/stocks/AXTA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$34.12−0.76 (−2.18%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
No open-market purchase by an insider of Axalta was filed in the last 90 days. The latest on record was on Sep 13, 2023.
Since 2014, Axalta insiders reported 8 open-market purchases and 248 sales on Forms 4 and 5, with purchases in 3 different years, most recently 2023.
No open-market sale by an insider of Axalta (AXTA) was filed with the SEC in the last 90 days.
No trade in Axalta (AXTA) was disclosed by a member of Congress in the last 12 months.
Axalta's next results are expected on Feb 8, 2027, before the market opens. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
+18.8% (+$5.41) from Nov 20, 2025 to Nov 20, 2026 · adjusted daily closes
Adjusted close went from $28.71 on Nov 20, 2025 to $34.12 on Nov 20, 2026 (+18.8%). Disclosed in this range: 0 insider trades, 0 pre-arranged insider sales, 0 Congress trades, and 24 13F position changes for 3 quarters ending in it.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Specialty Chemicals company based in Philadelphia, Pennsylvania.
Last 12 months
+18.8%
Market value
$7.3B
S&P 500 +5.7% over the same dates. Prices adjusted for splits and dividends.
Short interest: 8.9M shares sold short (4.2% of shares outstanding), −6.4% vs the previous count, 4.7 days of normal trading to buy them back. FINRA, as of Oct 30, 2026. Short interest history
Revenue, fiscal 2025
$5.12B
−3.0% vs the year before
Net income, fiscal 2025
$378M
As reported in the annual filing
Shares outstanding
214M
As of Oct 22, 2026
In fiscal 2025 the company spent $165M buying back its own shares. Cash actually paid, from its cash-flow statement.
Fund moves
7 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
8 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
8 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
9 tracked managers disclosed the same change for Q2 2026. Among this manager's largest new positions for Q2 2026.
Fund moves
8 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 13, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Insiders of Axalta reported 8 open-market purchases and 248 sales since 2014; purchases in 3 different years, most recently 2023.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $492K2×2 trades |
| 2023 | $3.13M6×6 trades | $1.77M5×5 trades |
| 2022 | $49K1×1 trade | — |
| 2021 | — | $1.34M3×3 trades |
| 2020 | — | $15.4M5×5 trades |
| 2019 | — | $51.3M37×37 trades |
| 2018 | — | $47.3M42×42 trades |
| 2017 | $113K1×1 trade | $39.8M35×35 trades |
| 2016 | — | $3.95B28×28 trades |
| 2015 | — | $5.71B89×89 trades |
| 2014 | — | $2.13B2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Nobody is above 5% on the latest filings: every recent filer has reported going below the line.
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
Against the S&P 500 over the year
Since Nov 19, 2025, AXTA is up 22.7% and the index fund is up 4.1%: 19 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much AXTA moves
Beta 1.1 (1 year vs SPY)
End-of-day prices. These figures describe the past year and say nothing about what comes next. Beta: how much the stock moved, on average, for each 1% move of the S&P 500 fund over 251 trading days (1 = in step with it).
Written by OQRO's software from the last 12 months on record · Nov 19, 2026
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Insiders
Funds and stakes
Contracts, lobbying and filings
Company reports, price and press
Who holds it
Deals
Things to keep in mind
The three months Jul 1, 2026 to Sep 30, 2026, compared with the same quarter a year earlier, from the quarterly report filed Oct 29, 2026. Quarterly reports are not audited. Read the filing
−1.2% on the same quarter a year earlier ($828M)
+7.2% on the same quarter a year earlier ($460M)
+0.2% on the same quarter a year earlier ($444M)
−2.6% on the same quarter a year earlier ($455M)
+6.7% on the same quarter a year earlier ($223M)
+11% on the same quarter a year earlier ($166M)
Fiscal year Jan 1, 2025 to Dec 31, 2025, from the annual report filed Feb 13, 2026. Read the filing
−5.2% on the year before ($3.46B)
+1.0% on the year before ($1.82B)
+2.2% on the year before ($1.78B)
Every annual report has a section where the company's managers explain the year's results (Item 7, Management's discussion and analysis). In this report it runs to about 10,000 words.
We are a leading global manufacturer, marketer and distributor of high-performance coatings systems and products. We have over a 150-year heritage in the coatings industry and are known for manufacturing high-quality products with well-recognized brands supported by market-leading technology and customer service. Our diverse global footprint of 42 manufacturing facilities, four technology centers, 48 customer training centers and approximately 12,300 team members allows us to meet the needs of customers in over 140 countries. We serve our customer base through an extensive sales force and technical support organization, as well as through over 5,000 independent, locally based distributors. We operate our business in two operating segments, Performance Coatings and Mobility Coatings.
Source: SEC EDGAR, Form 10-K filed Feb 13, 2026 and Form 10-Q filed Oct 29, 2026. Revenue lines are the figures the company tags in its filing; OQRO shows a split only when its lines add up to the reported total revenue. The quote is the opening of the managers' discussion, cut at a sentence; the word count is estimated from its length. Not investment advice.
−13% on the year before ($2.01B)
+4.6% on the year before ($862M)
+2.3% on the year before ($616M)
And 26 more headings in the filing.
Revenue
$1.31B
+1.8% vs the same quarter a year earlier
Free cash flow, last 12 months
$497M
This quarter $89M, a year earlier $87M
Net debt
$2.35B
Debt $3B, cash $650M, at Sep 30, 2026
Net income, last 12 months
$334M
Operating profit covers interest 4.18x (latest fiscal year)
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Oct 29, 2026.
Revenue and earnings history, 12 fiscal yearsEarnings dates and the stock's moves
Latest annual report filed Feb 13, 2026, compared with the one filed Feb 13, 2025. Read the filing
And 4 more headings in the filing.
We are from time to time party to legal proceedings that arise in the ordinary course of business. We are not involved in any litigation other than that which has arisen in the ordinary course of business. We do not expect that any currently pending lawsuits will have a material adverse effect on us as discussed in Note 5 to the consolidated financial statements included elsewhere in this Annual Report on Form 10-K.
The company describes its cases in the notes to its financial statements, in the same filing.
Source: SEC EDGAR, Form 10-K filed Feb 13, 2026. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.
4 certified in FY2026 Q3, vs 1 a year earlier. 4 positions in total, median offered wage $105K a year.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
Last results
Oct 29, 2026
Within the 30 days after it, until Nov 28, 2026
Next results, expected
Feb 8, 2027
before the market opens; the date can move until the company confirms it
Purchases after results
Not enough history
From Axalta's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Axalta's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
Fails to deliver: 84K shares (about $2.92M) were not delivered on time for settlement on Oct 29, 2026. SEC fails-to-deliver data.
Fails to deliver have many causes, including processing delays, and are often resolved within days.
Off-exchange trading: 40.3% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (24.7% on ATS, 15.6% with other brokers), below its 26-week average of 42.9%. Weeks of Oct 5 to Oct 30, 2026.
Largest ATS: UBS ATS (13.3%), INTELLIGENT CROSS LLC (12.0%), SIGMA X2 (11.5%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.